| CAS NO: | 522-48-5 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 250mg | 电议 |
| 500mg | 电议 |
| 1g | 电议 |
| 2g | 电议 |
| 5g | 电议 |
| 10g | 电议 |
| Molecular Weight (MW) | 236.74 |
|---|---|
| Formula | C13H16N2.HCl |
| CAS No. | 522-48-5 |
| Storage | -20℃ for 3 years in powder form |
| -80℃ for 2 years in solvent | |
| Solubility (In vitro) | DMSO: 12 mg/mL (50.7 mM) |
| Water: 47 mg/mL (198.5 mM) | |
| Ethanol: 26 mg/mL (109.8 mM) | |
| Other info | Chemical Name: 1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, hydrochloride (1:1) InChi Key: BJORNXNYWNIWEY-UHFFFAOYSA-N InChi Code: InChI=1S/C13H16N2.ClH/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13;/h1-2,4,6,12H,3,5,7-9H2,(H,14,15);1H SMILES Code: [H]Cl.C1(C2CCCC3=C2C=CC=C3)=NCCN1 |
| Synonyms | Tetryzoline; Tyzanol; Tyzine; Vasopos; Visine. Tetrahydrozoline HCl, Tetrahydrozoline hydrochloride; |
| In Vitro | In vitro activity: Tetrahydrozoline HCl is an imidazoline derivative with alpha receptor agonist activity. Its main mechanism of action is the constriction of conjunctival blood vessels |
|---|---|
| In Vivo | Tetrahydrozoline HCl inhibits settlement of the Barnacle Balanus improvisus at 1μM |
| Animal model | |
| Formulation & Dosage | |
| References | Clin Toxicol (Phila). 2008 Feb;46(2):171-2; J Exp Zool A Comp Exp Biol. 2005 Jul 1;303(7):551-62. |
m.cnreagent.com